February 2, 2023

Eli Lilly Covid-19 Antibody Drug Shipments Paused Over Variant Concerns

U.S. health officials have paused the distribution of two

Eli Lilly

LLY -1.18%

& Co. Covid-19 monoclonal antibody treatments because of data showing that they aren’t effective against virus variants that are becoming increasingly common across the country.

The Department of Health and Human Services said Friday that it is immediately pausing all distribution of bamlanivimab and etesevimab together, as well as etesevimab alone to be paired with existing supplies of bamlanivimab, in the U.S. until further notice.

Health administrators cited analyses that found that the two antibody treatments together weren’t effective against two variants: the Gamma variant, first identified in Brazil, and the Beta variant, first identified in South Africa.

These variants account for more than 11% of Covid-19 cases, a share that is growing, according to the Centers for Disease Control and Prevention.

Distribution of the antibody treatments was already paused because of concerns regarding their effectiveness with the variants in at least nine states including Rhode Island, Arizona, California, Florida, Washington and Massachusetts.

Lilly said that the company is working with governments and regulators to ensure antibodies are available to appropriate patients as variants continue to evolve.

The move comes after Lilly in April asked U.S. health regulators to revoke the authorization for use of bamlanivimab alone because of its lack of potency against some strains of the virus.

At the time the drugmaker said it would focus on distributing a drug cocktail containing bamlanivimab and etesevimab, citing studies that it would neutralize more of the variants when given together. The Food and Drug Administration granted the request.

Instead of the two treatments produced by Lilly, the FDA recommends healthcare providers use

Regeneron Pharmaceuticals Inc.’s

REGEN-COV, which has been approved for use since last November, and

Vir Biotechnology Inc.

and

GlaxoSmithKline

PLC’s sotrovimab, which was approved in May.

Both monoclonal antibody therapies were approved for the same use as Lilly’s treatments, and U.S. health authorities found that those treatments are likely to work in spite of the two variants.

The move reveals how emerging variants could pose challenges to both treatments and vaccines. The U.S. is racing to vaccinate Americans as more variants, including the highly transmissible Delta variant, gain a foothold in the country.

The Delta strain, which was first identified in India, could become the dominant strain in the U.S. in the coming weeks, according to researchers.

Monoclonal antibodies are engineered proteins that mimic the immune system’s response to fight off viruses. Lilly’s first treatment, bamlanivimab, was the first to receive emergency-use authorization in November for use in patients with earlier-stage Covid-19 who aren’t hospitalized but are at high risk. In February, the FDA authorized the combination of bamlanivimab with etesevimab, administered together for patients who are at risk of worsening to severe Covid-19, including those with certain medical conditions or who are ages 65 and over.

Meanwhile,

Roche Holding AG

announced Friday that the FDA has authorized the company’s drug Actemra for treatment of adults and children ages 2 and older who are hospitalized for Covid-19 and are receiving corticosteroids and require oxygen or breathing support.

Write to Laura Cooper at [email protected]

Copyright ©2020 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Related Posts

Deere Workers Reject Second Contract Offer, Extending Strike

November 3, 2021

November 3, 2021

Workers at Deere & Co. rejected a second contract offer, extending a strike against the farm equipment and construction machinery...

Food Companies Say Combating Climate Change Comes With Costs

June 24, 2021

June 24, 2021

Food companies are investing billions of dollars into sustainability efforts, betting that costs will fall and consumers will remain interested...

Facebook Lets More Employees Choose Full-Time Remote Work or Return to the Office

June 9, 2021

June 9, 2021

Facebook Inc. is giving most of its employees a choice: Seek permission to keep working at home or go to...

PG&E Warns of More Blackouts During California’s Wildfire Season

June 11, 2021

June 11, 2021

PG&E Corp. said it is likely to proactively cut power to customers in Northern California more frequently this fall in...

U.S. Home Prices Push to Record High, Slowing Pace of Purchases

May 21, 2021

May 21, 2021

America’s home-buying frenzy is cooling off for the first time since it heated up last year, as limited inventory and...

European Privacy Ruling Could Mean More Scrutiny of Companies

June 14, 2021

June 14, 2021

The European Union’s top court is set to weigh in Tuesday on whether a privacy regulator in one country can...

Colonial Pipeline Missed Requested Security Review Before Hack

May 26, 2021

May 26, 2021

Colonial Pipeline Co. last year didn’t undergo a requested federal security review of its facilities and was in the process...

Epic Games Faces Apple in Final Day of Courtroom Battle Over Monopoly Claims

May 24, 2021

May 24, 2021

Lawyers for Apple Inc. AAPL 1.79% and Epic Games Inc. on Monday began making their final arguments to a judge...

Two Fed Officials Say They Are Ready to Weigh Stimulus Pullback

June 21, 2021

June 21, 2021

Two Federal Reserve officials said that the day for the U.S. central bank to pull back on bond buying is...

U.S. Trade Deficit Narrowed Amid Supply Chain Woes

June 8, 2021

June 8, 2021

WASHINGTON—The U.S. trade deficit narrowed in April from a record level in March as disruptions in global supply chains and...

Miners Try to Get Covid-19 Vaccines Into Areas Where Shots Are Scarce

June 12, 2021

June 12, 2021

Mining companies are throwing their weight behind vaccination efforts as Covid-19 continues to ravage much of the developing world. Miners...

Google Nears Settlement of Ad-Tech Antitrust Case in France

May 27, 2021

May 27, 2021

Alphabet Inc.’s GOOG -1.27% Google is nearing a settlement of an antitrust case in France alleging the company has abused...

Covid-19 Aid to Concert Halls, Theaters Set to Be Distributed Next Week

May 21, 2021

May 21, 2021

WASHINGTON—The Small Business Administration is aiming to start awarding Covid-19 aid to concert halls, theaters and other live-entertainment venues early...

Trump Organization and CFO Allen Weisselberg Expected to Be Charged Thursday

June 30, 2021

June 30, 2021

The Manhattan district attorney’s office is expected to charge the Trump Organization and its chief financial officer with tax-related crimes...

Funding for Bezos Space Company Fails to Launch in House

June 18, 2021

June 18, 2021

HOUSE THROWS UP ROADBLOCKS to funding for Jeff Bezos’s Blue Origin space exploration company that was approved as part of...